| Interactions between Xenobiotics and DME (XEOTIC)
|
| Fungicide(s), Herbicide(s) or Insecticide(s) |
| Herbicide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Atrazine |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00969
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Herbicide |
| DME Modulation |
Atrazine up-regulates the expression of DME APRT |
[1] |
| Health or Environmental Toxicant(s) |
| Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Ethyl methanesulfonate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00772
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen |
| DME Modulation |
Ethyl methanesulfonate inhibits the expression of DME APRT |
[2] |
| Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Perfluorooctane sulfonic acid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00921
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health and Environmental Toxicant |
| DME Modulation |
Perfluorooctane sulfonic acid up-regulates the expression of DME APRT |
[3] |
| Mycotoxin |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Beauvericin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01513
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Mycotoxin |
| DME Modulation |
Beauvericin inhibits the expression of DME APRT |
[4] |
| Natural Product(s), Extract(s) or Medicine(s) |
| Natural Mixture |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Tobacco smoke pollution |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00821
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Mixture |
| DME Modulation |
Tobacco smoke pollution inhibits the expression of DME APRT |
[5] |
| Pharmaceutical Agent(s) |
| Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 4 Xenobiotics
|
| Aspirin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00213
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Aspirin inhibits the expression of DME APRT |
[6] |
| Copper sulfate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Copper sulfate inhibits the expression of DME APRT |
[7] |
| Doxorubicin hydrochloride |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00292
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Doxorubicin hydrochloride up-regulates the expression of DME APRT |
[8] |
| Urethane |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00435
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Urethane inhibits the expression of DME APRT |
[9] |
| Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Genistein |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00557
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Genistein induces the drug-metabolizing activity of DME APRT |
[10] |
| Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Sodium arsenite |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00632
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Sodium arsenite inhibits the drug-metabolizing activity of DME APRT |
[11] |
| Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
| (+)-JQ1 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00723
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug in Preclinical Study |
| DME Modulation |
(+)-JQ1 inhibits the expression of DME APRT |
[12] |
| GSK-J4 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01324
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Patented Pharmaceutical Agent |
| DME Modulation |
GSK-J4 inhibits the expression of DME APRT |
[13] |
| ICG-001 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01336
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Patented Pharmaceutical Agent |
| DME Modulation |
ICG-001 inhibits the expression of DME APRT |
[14] |
|
|
|
|
|
|